Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 24,813 $ 19,206
Marketable securities 56,969 0
Accounts receivable, net (including allowance of $169 and $148 as of December 31, 2025 and 2024, respectively) 4,178 11,926
Contract assets 1,778 785
Other current assets 6,036 3,278
Assets classified as held for sale 0 56,963
Total current assets 93,774 92,158
Property and equipment, net 80,806 63,338
Operating lease right-of-use assets 10,798 11,074
Goodwill 15,450 14,735
Other intangible assets 9,079 10,161
Other long-term assets, including restricted cash 1,085 2,109
Total assets 210,992 193,575
Current liabilities    
Accounts payable 14,866 11,592
Long-term debt, current portion 0 93,936
Contract liabilities, current portion 35,160 22,037
Other accrued expenses 22,266 16,361
Liabilities associated with assets classified as held for sale 0 7,667
Total current liabilities 72,292 151,593
Contract liabilities, non-current 14,207 23,489
Warrant liability 106 13,641
Operating lease liabilities, net of current portion 8,755 9,598
Other long-term liabilities 2,704 6,941
Total liabilities 98,064 205,262
Commitments and contingencies (Note 10)
Stockholders' equity    
Common stock, $0.0001 par value, 1,000,000,000 Class A and 15,000,000 Class B shares authorized, 33,107,807 Class A and 1,507,325 Class B shares issued and outstanding at December 31, 2025; 25,711,165 Class A and 1,507,325 Class B shares issued and outstanding at December 31, 2024 3 3
Additional paid-in capital 605,700 536,725
Accumulated other comprehensive loss (5,435) (9,770)
Accumulated deficit (487,340) (538,645)
Total stockholders' equity 112,928 (11,687)
Total liabilities and stockholders' equity $ 210,992 $ 193,575